{
  "id": "api:x402-20105efae5080f41",
  "kind": "api",
  "name": "clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal",
  "description": "Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.",
  "category": "x402",
  "url": "https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal",
  "price": null,
  "x402": true,
  "meta": {
    "network": "eip155:8453",
    "scheme": "exact",
    "pay_to": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
    "method": "GET",
    "last_updated": "2026-10-16T02:44:11.317Z"
  },
  "trust": {
    "verified": true,
    "uptime_pct": 100,
    "latency_ms": 222,
    "checks": 1
  }
}